Recent reviews have pointed to GLP-1 receptor agonists as a potential option, and they have also highlighted the need for biomarker guided ways to pick the right patients
In conducting our literature search, we aimed to comprehensively cover all significant HDT approaches for TB that have been reported over the years
"GLP-1 medications are powerful tools, but they are not passive treatments, and patients who combine them with proper nutrition, strength training and medical oversight are more likely to achieve healthier and more sustainable outcomes," she said.
Why Individual Receptor Sensitivity Matters for Side Effect Risk Your genetic makeup influences how strongly your GLP-1 receptors respond to medication, which affects both efficacy and side effects
Finally, there were differences in trial designs, patient characteristics, background therapy, and endpoint definitions